NORTHCAPE WEALTH MANAGEMENT, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1902806
WILLIAMSVILLE, NY
Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$231,707
-$23,479 QoQ
Shares Held
1,834
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,834
of 2,266 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHCAPE WEALTH MANAGEMENT, LLC holds $20,887,835 across 10 Drug Manufacturers - General names. GILD ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
27,388 | $6,955,730 | |
| 2 | LLY |
ELI LILLY & Co
|
4,618 | $5,538,968 | |
| 3 | ABBV |
AbbVie Inc.
|
12,110 | $3,047,360 | |
| 4 | NVS |
Novartis AG
|
8,271 | $1,296,231 | |
| 5 | AMGN |
Amgen Inc
|
2,974 | $1,076,944 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,353 | $1,073,360 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,898 | $685,562 | |
| 8 | PFE |
Pfizer Inc
|
27,196 | $654,879 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,707 | 1,834 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $255,186 | 1,831 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $222,159 | 1,810 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $221,112 | 1,992 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $220,298 | 1,987 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $229,926 | 2,052 | Shares | Sole | 2025-04-25 | |
| 2022-09-30 | $369,152 | 5,984 | Shares | Sole | 2022-11-08 | |
| 2022-03-31 | $336,189 | 5,655 | Shares | Sole | 2022-04-18 | |
| No filing history on record for this holder in this stock. | ||||||